BARCLAYS PLC - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 38 filers reported holding ETON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$11,000
-56.0%
2,137
-46.4%
0.00%
Q2 2021$25,000
-76.0%
3,990
-72.1%
0.00%
Q1 2021$104,000
+131.1%
14,278
+159.1%
0.00%
Q4 2020$45,000
-15.1%
5,511
-18.0%
0.00%
Q3 2020$53,000
+17.8%
6,720
-16.7%
0.00%
Q2 2020$45,000
-35.7%
8,064
-8.4%
0.00%
Q1 2019$70,0008,8000.00%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,430,270$10,134,2263.30%
Westside Investment Management, Inc. 528,310$2,203,0600.63%
Acuitas Investments, LLC 219,000$913,2300.54%
EAM Investors, LLC 256,623$1,070,1180.21%
Parkman Healthcare Partners LLC 165,000$688,0500.13%
ESSEX INVESTMENT MANAGEMENT CO LLC 110,016$458,7670.08%
PARADIGM CAPITAL MANAGEMENT INC/NY 300,000$1,251,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 271,462$1,131,9970.03%
Quantum Private Wealth, LLC 11,500$47,9550.02%
CHICAGO TRUST Co NA 16,700$69,6390.02%
View complete list of ETON PHARMACEUTICALS INC shareholders